Charles River Laboratories International Inc. (CRL)
EPAM Systems Inc. (EPAM)
EPAM Systems, Inc. - EPAM to Host Investor Day on March 12, 2026
Ginkgo Bioworks Holdings Inc. (DNA)
Ginkgo Bioworks - Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
Edgewise Therapeutics Inc (EWTX)
Edgewise Therapeutics - Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026
Omnicell Inc (OMCL)
Omnicell - Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
Johnson & Johnson (JNJ)
Johnson & Johnson - Johnson & Johnson elevates leadership in depression with new data at 2026 American College of Neuropsychopharmacology Annual Meeting
Natera Inc (NTRA)
Natera - Natera Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling
Alto Neuroscience Inc. (ANRO)
Alto Neuroscience, Inc. - Alto Neuroscience Presents New Data at the 64th Annual Meeting of the American College of Neuropsychopharmacology
Omnicell Inc (OMCL)
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
Kala Pharmaceuticals Inc. (KALA)
Acadia Healthcare Company Inc (ACHC)
CytoMed Therapeutics Ltd (GDTC)
CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital
Johnson & Johnson (JNJ)
Johnson & Johnson elevates leadership in depression with new data at 2026 American College of Neuropsychopharmacology Annual Meeting
Evaxion Biotech A/S (EVAX)
Evaxion expands AI-Immunology™ platform into autoimmune diseases